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lipids in the outer leaflet of the bacterial cytoplasmic gered by induction of this clever defense system (Mina-
gawa et al., 2003).membrane via a divalent Mg2+ bridge (see Figure 1).
Removal of Mg2+ ions or their displacement by cationic
antimicrobial peptides induces a structural transition in
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PhoQ that is translated across the cytoplasmic mem-
brane, promoting phosphorylation of PhoP. Cationic an-
timicrobial peptides, despite great diversity of struc- University of British Columbia
ture, tend to fold into amphipathic structures that lie on Vancouver, British Columbia
the surface of the bacterial cytoplasmic membrane with V6T 1Z4, Canada
their positive charges facing outwards; hence, they are
Selected Readingideally suited to interacting with the membrane-facing
anionic patch of PhoQ.
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Salmonella bacteria enter host cells by binding to the
gastric mucosa and are taken up by a variety of host
cell types including phagocytes. Once inside host cells,
this pathogen resides in vesicles of host origin called
Salmonella-containing vesicles and resists destruction.
It is striking that Salmonella has evolved a mechanism
that harnesses host antimicrobial peptides to switch on
its own defense system, PhoPQ, which enables the
pathogen to become resistant to the antimicrobial pep-
tides as well as to other cationic defense molecules
such as the antibiotic polymyxin. When PhoPQ is acti-
vated, the lipid A portion of LPS—which anchors LPS
in the outer membrane of Gram-negative bacteria—
becomes modified by aminoarabinose and fatty acids,
which decreases the negative charge and fluidity of the
bacterial outer membrane. This results in decreased
binding and uptake of cationic antimicrobial peptides
across the bacterial outer membrane, leading to resis-
tance of Salmonella to these peptides. Modification of
the lipid A portion of LPS by PhoPQ also reduces by
up to 100-fold the ability of Salmonella LPS to induce
host innate immunity via TLR4 (Kawasaki et al., 2004),
resulting in muting of the host immune response. Fur-
thermore, the regulation by PhoPQ of more than 200
bacterial genes involved in chemotaxis/motility, drug
resistance, transport, and heme biosynthesis indicates
that a substantial shift in bacterial physiology is trig-DOI 10.1016/j.cell.2005.07.023
Transposons Reanimated in Mice
Transposons have proved valuable in the genetic modi-
fication of many organisms but not mammals. New
work reported by Ding et al. (2005) in this issue of Cell
and by Collier et al. (2005) and Dupuy et al. (2005) in
a recent issue of Nature now reveals that insertional
mutagenesis in mammalian cells is possible thanks
to modified derivatives of the piggyBac and Sleeping
Beauty DNA transposons. However, the slow rate of
proliferation of DNA transposons suggests that deriv-
atives of the L1 retrotransposon might be more pow-
erful for mutagenesis of germline cells. In either case,
the future of transposon-driven genetic analyses of
mice and other mammals looks promising.
Transposable elements or transposons are mobile ge-
netic elements that move around within the genome of
an organism. Because they can insert themselves close
to or within genes, transposons can be used to inacti-
vate genes by insertional mutagenesis and in so doing
provide information about the gene’s function. Transpo-
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323Figure 1. A Comparison of DNA Transposons
and Retrotransposons
Mode of reproduction of the DNA transposons
piggyBac and Sleeping Beauty (A) and of L1
retrotransposons (B). The cut-and-paste
replicative mechanism of DNA transposons
(blue) limits their rate of proliferation to a
maximum of 1.5-fold per cell generation. In
contrast, the copy-and-paste mechanism of
retrotransposons (red) places no limits on
their rate of increase. Most L1 insertions are
partial due to 5# truncation, which limits the
amount of sequence that can be delivered
via these elements. Reverse transcriptase
(RT) acts almost solely on the L1 RNA from
which it was translated (Moran et al., 1996).
In contrast, transposase can be encoded by
unlinked transgenes, and one transposase
gene can mobilize an entire population of
cognate DNA transposons. (DSB, double-
strand break at former site of mobilized
transposon.)sons have been modified and used for the genetic ma-
nipulation of many lower organisms, from flowering
plants to the fruit fly Drosophila. However, the value of
transposons for insertional mutagenesis in mammalian
cells has been very limited because they insert infre-
quently and carry only small amounts of DNA. This is
set to change with the reports of a new transposon
called piggyBac from the cabbage looper moth (Ding
et al., 2005) and the modification of an existing transpo-
son, Sleeping Beauty, first identified in salmonid fishes
(Ivics et al., 1997; Collier et al., 2005; Dupuy et al.,
2005). In their study, Ding et al. (2005) demonstrate that
piggyBac can carry multiple genes and not only inserts
itself efficiently into the genomes of human and mouse
somatic cells but also demonstrates efficient insertion
into the genome of mouse germline cells. Meanwhile,
Dupuy et al. (2005) have modified the existing Sleeping
Beauty transposon so that it is mobilized in mouse so-
matic cells, and Collier et al. (2005) apply the modified
Sleeping Beauty transposon to identify genes involved
in the formation of solid tumors in mice.
DNA transposons are excised from one location in
the genome and are reinserted at another (usually
neighboring) location through the action of specific en-
zymes called transposases (Figure 1). These enzymes
can be encoded by transgenes and expressed via in-
ducible or tissue-specific promoters to mobilize un-linked transposons in a regulated manner. The specific-
ity of the integration site is limited only to TA for
Sleeping Beauty and to TTAA for piggyBac. The DNA
transposon piggyBac can carry as much as 14 kb of
DNA (Ding et al., 2005). This means that gene traps in
the form of splice donor and acceptor sites can be in-
corporated into the transposon to fuse transposon-
borne reporter genes to cellular host transcripts (Collier
et al., 2005). DNA transposons do not normally encode
functional splice sites, and the addition of such sites
allows gene truncation by transposons within introns at
any distance from the flanking exons. Polyadenylation
sites can be included to terminate transcripts and am-
plify the effects of DNA transposons on the transcrip-
tion of host genes. New insertion sites can be identified
by inverse PCR, although this becomes more difficult
as transposon copy number increases. Confirmation
that a phenotype has been caused by the insertion of
a transposon can be obtained by reexposure to the
transposase, which “hops” the transposon to another
site in the genome, usually with restoration of the wild-
type sequence at the first insertion site. Reversion of
the phenotype after removal of the transposon provides
direct evidence that the transposon insertion was re-
sponsible for the observed phenotype.
As Collier et al. (2005) demonstrate for Sleeping Beauty
derivatives, DNA transposons have many important
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324applications, including the identification of oncogenes a
and tumor suppressor genes in tissues that are not ac- c
cessible to classical retrovirus insertional mutagenesis. B
The power and flexibility of transposon mutagenesis by m
piggyBac and by Sleeping Beauty derivatives are im- H
pressive, but there are limitations. DNA transposons t
move by cut-and-paste transposition—that is, copy r
number increases only if a newly replicated transposon t
is excised during S phase and inserted into unrepli- c
cated DNA ahead of a replication fork elsewhere in the s
genome. Thus, copy number can only increase at a g
maximum rate of 1.5-fold per cell generation, which is s
rather low for phenotype-based forward genetic
screens. A large pool of source transposons in trans- t
gene concatemers increases insertion numbers as (
transposons can be mobilized out of the array, but the m
total number of new insertions cannot much exceed the D
number of transposons in the concatemer. The actual t
copy number limit is unknown but might be only a few f
hundred, and the effective number is likely to be lower. D
Forward genetics in germline cells by transposon muta- t
genesis may be limited by copy number constraints. t
Although DNA transposons may turn out to be a v
“dream tool” for forward genetic screens (Ding et al., g
2005), there are obstacles that have yet to be over- t
come. The results of specific locus tests (Hitotsumachi o
et al., 1985) will be required to determine whether DNA l
transposons are viable mutagens in forward genetic g
screens. r
Unlike DNA transposons, retrotransposons (mobile (
elements that transpose via reverse transcription of an T
RNA intermediate) can increase in copy number very s
rapidly thanks to their copy-and-paste mode of repro- i
duction, and there is no a priori limit to the rate of in-
crease in retrotransposon copy number (see Figure 1). d
This gives retrotransposons an advantage over DNA o
transposons, which increase in copy number more s
slowly. The most active autonomous mammalian retro- u
transposon, the LINE 1 (L1) element, encodes a reverse g
transcriptase that acts only on the RNA that encodes m
it, presumably by cotranslational binding of the nascent s
protein to the L1 RNA (Moran et al., 1996). New inser- B
tions are unlinked to the source element, but most new s
insertions are represented by very short and hetero-
t
geneous lengths of 3# L1 sequence. This limits the
“payload” that recombinant L1 elements can deliver
Tand constrains the design of vectors for insertional mu-
Dtagenesis in a way that does not apply to DNA transpo-
Csons. However, compact 3#-encoded epitope tags on
stable peptides and splice donor and acceptor sites
Nwill be found in a significant fraction of partially inserted
L1 element derivatives. It is also not possible to remove
an L1 insertion, as can be done for DNA transposons
Sby reexposing them to transposase. There is evidence
that the endogenous L1 promoter is most active in
Bgermline cells (Ostertag et al., 2002; Bourc’his and Bes-
Btor, 2004), which renders retrotransposons appropriate
Cagents for forward genetic screens.
gProliferation rates for endogenous L1 elements are
Dlow because of host silencing responses and inherent
iinefficiencies in L1 transposition. However, it should be
Dpossible to increase the transposition frequency of L1
Jelements by modifying them or by introduction of L1
family members from other animal species. Ostertag et Hl. (2002) have shown that modified human L1 elements
an be mobilized in the mouse germline, and Han and
oeke (2004) produced a synthetic L1 element that was
ore active in transposition than its parent element.
owever, unlike Sleeping Beauty and piggyBac, con-
rolled insertional mutagenesis of somatic cells by de-
ivatives of L1 elements has not been reported. None-
heless, the high rates of proliferation that L1 elements
an achieve in germline cells suggest that properly de-
igned L1 derivatives might be better suited to forward
enetic screens than DNA transposons with their
lower proliferation rates.
Efficient mutagenesis by transposons requires the
emporary disablement of genome defense systems
Bestor, 2003). Endogenous transposons can be reani-
ated by demethylation of transposon promoters in
nmt3L-deficient male germ cells (Bourc’his and Bes-
or, 2004). Dnmt3L is a germ-cell-specific regulatory
actor related in sequence to the Dnmt3A and Dnmt3B
NA methyltransferases with which it physically in-
eracts. Removal of Dnmt3L causes very high levels of
ranscripts of L1 elements and endogenous retro-
iruses to accumulate in male germ cells, which sug-
ests that endogenous transposons could be induced
o proliferate in germ cells that carry conditional alleles
f Dnmt3L. In such cells, transposons would be al-
owed to transpose in the absence of Dnmt3L, and the
ene encoding this methyltransferase then would be
eactivated at the latest stage compatible with fertility
constitutive null alleles of Dnmt3L cause azoospermia).
his system, combined with gene-trap retrotranspo-
ons, could provide very high but controlled rates of
nsertional mutagenesis in the male germline.
Domesticated transposons have been comman-
eered for a number of different applications in various
rganisms. The new studies show that DNA transpo-
ons and their derivatives will be as valuable for manip-
lating mammalian genomes as they have been for the
enetic analysis of many other organisms. Mammalian
olecular geneticists finally have two powerful transpo-
ons to work with in the form of piggyBac and Sleeping
eauty. Meanwhile, new derivatives of L1 retrotranspo-
ons promise to provide highly efficient insertional mu-
agenesis of the mammalian germline.
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